Aethlon Medical (AEMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2005 | 03-2004 | 03-2003 | 03-2002 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,097 | -1,519 | -2,461 | -3,996 | -4,423 |
| Depreciation Amortization | 109 | 452 | 160 | 204 | 228 |
| Accounts receivable | N/A | N/A | N/A | 5 | 57 |
| Other Working Capital | -334 | 387 | 943 | 633 | 116 |
| Other Operating Activity | 763 | 138 | 844 | 2,147 | 3,221 |
| Operating Cash Flow | $-1,559 | $-542 | $-515 | $-1,007 | $-801 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -5 | -1 | -31 | 11 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 2 |
| Purchase Sale Intangibles | N/A | N/A | -49 | -47 | -137 |
| Other Investing Activity | 0 | 0 | -49 | -47 | -137 |
| Investing Cash Flow | $-30 | $-5 | $-50 | $-78 | $-124 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 200 | 275 | 128 | 100 |
| Debt Issued | 130 | N/A | 65 | 50 | 708 |
| Common Stock Issued | 1,489 | 522 | 230 | 912 | N/A |
| Other Financing Activity | -23 | -180 | -10 | 0 | -94 |
| Financing Cash Flow | $1,596 | $542 | $560 | $1,090 | $714 |
| Beginning Cash Position | 2 | 6 | 11 | 6 | 217 |
| End Cash Position | 9 | 2 | 6 | 11 | 6 |
| Net Cash Flow | $7 | $-5 | $-4 | $5 | $-211 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,559 | -542 | -515 | -1,007 | -801 |
| Capital Expenditure | -30 | -5 | -1 | -31 | -7 |
| Free Cash Flow | -1,590 | -547 | -516 | -1,038 | -807 |